Mar 07, 2022 / 04:00PM GMT
Elliot Henry Wilbur - Raymond James & Associates, Inc., Research Division - Senior Research Analyst
Good morning. Welcome to Raymond James 43rd Annual Institutional Investor Conference. My name is Elliot Wilbur. I'm the coverage analyst at Raymond James, following the animal health and specialty pharmaceutical space. Welcome to the IDEXX Laboratories' presentation at the 43rd Annual IIC.
IDEXX is the global leader in the Companion Animal Diagnostics market. Presenting for the company this morning is IDEXX' CEO, Jay Mazelsky.
Jonathan J. Mazelsky - IDEXX Laboratories, Inc. - President, CEO & Director
Thank you, Elliot, for the introduction. Good morning. Welcome to the strategic overview of the IDEXX business. I'm Jay Mazelsky, CEO of IDEXX, and it's just a great pleasure to welcome all of you here in the room and those participating in the webcast to today's events.
I'd also like to mention with me today in the room, we have Michael Schreck, who's Senior Vice President and General Manager of the Veterinary Software and Services
IDEXX Laboratories Inc at Raymond James Institutional Investors Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot